Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Authors:
- Jordi BruixJordi Bruix
- Morris ShermanMSMorris Sherman
- Josep M LlovetJosep M Llovet
- Michel BeaugrandMBMichel Beaugrand
- Riccardo LencioniRLRiccardo Lencioni
- Andrew K BurroughsABAndrew K Burroughs
- Erik ChristensenECErik Christensen
- Luigi PagliaroLPLuigi Pagliaro
- Massimo ColomboMCMassimo Colombo
- Juan RodésJRJuan Rodés
Top Cited Papers
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 35 (3) , 421-430
Abstract
No abstract availableThis publication has 120 references indexed in Scilit:
- Hepatobiliary surgeryJournal of Hepatology, 2000
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Microwave coagulation therapy for hepatocellular carcinomaGastroenterology, 1996
- No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosisJournal of Hepatology, 1995
- Controlled trial of tamoxifen in patients with advanced hepatocellular carcinomaJournal of Hepatology, 1994
- Pharmacokinetics and toxicity of intraarterial Adriamycin for hepatocellular carcinoma: Effect of coadministration of lipiodolJournal of Hepatology, 1991
- Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifenJournal of Hepatology, 1990
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990
- Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary HemochromatosisNew England Journal of Medicine, 1985